Co-Authors
This is a "connection" page, showing publications co-authored by Eric Pamer and Matthew Odenwald.
Connection Strength
0.557
-
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049.
Score: 0.219
-
Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality. Sci Adv. 2025 Jun 06; 11(23):eadt1466.
Score: 0.061
-
Author Correction: Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration. Nat Microbiol. 2025 Jun; 10(6):1550.
Score: 0.061
-
Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration. Nat Microbiol. 2024 Jan; 9(1):55-69.
Score: 0.056
-
Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host Microbe. 2024 Jan 10; 32(1):117-130.e4.
Score: 0.055
-
Reduced immunomodulatory metabolite concentrations in peri-transplant fecal samples from heart allograft recipients. Front Transplant. 2023; 2:1182534.
Score: 0.054
-
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure. Nat Commun. 2022 11 03; 13(1):6615.
Score: 0.051